Fel-O-Vax FIV

This page contains information on Fel-O-Vax FIV for veterinary use.
The information provided typically includes the following:
  • Fel-O-Vax FIV Indications
  • Warnings and cautions for Fel-O-Vax FIV
  • Direction and dosage information for Fel-O-Vax FIV

Fel-O-Vax FIV

This treatment applies to the following species:
Manufacturer: Boehringer Ingelheim

Feline Immunodeficiency Virus Vaccine

Killed Virus

For subcutaneous vaccination of healthy cats 8 weeks of age or older as an aid in the prevention of infection with feline immunodeficiency virus. Efficacy was demonstrated in cats that received three doses of vaccine and were challenged one year post vaccination with a heterologous FIV strain. In one study the vaccine protected 67% of the vaccinates against infection (any cat that showed evidence of integration of the viral genome into its white blood cells was considered infected) while 74% of the controls became persistently viremic. In a more recent one year study, the vaccine protected 84% of the vaccinates against infection while 90% of the controls became persistently viremic.

DOSE: Inject one 1 mL dose subcutaneously using aseptic technique. Administer 2 additional doses at intervals of 2 to 3 weeks. Annual revaccination is recommended.

Infovax-id® System

The INFOVAX-ID System provides a simple and effective method of recording pertinent information on the vaccines administered to animals in a veterinary practice.

For vaccines requiring reconstitution, remove label from both vials and affix both labels to the animal’s medical chart.

Using the INFOVAX-ID System: U.S. Pat. No. 5,704,648

1.

Grasp the lower right hand corner of the tab at the arrow marked “Peel Here” between your thumb and forefinger (figure 1).

2.

Pull steadily at a slight upward angle until the top portion of the label is separated from the vial (figure 2).

3.

Place the label on the animal’s medical chart. Press down on the label to ensure adhesion.

Fel-O-Vax FIV Caution

Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In case of anaphylactoid reaction, administer epinephrine.

Thimerosal, neomycin and polymyxin B added as preservatives.

For Veterinary Use Only

U.S. Patent Nos. 5,037,753; 5,047,238; 5,275,813; 5,510,106; 5,846,825; 6,107,077; 6,254,872 B1; 6,447,993 B1; and patents pending.

© 2002 Fort Dodge Animal Health

Fel-O-Vax FIV Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package. (9 CFR Part 112.6)

Fort Dodge Animal Health, Fort Dodge, Iowa 50501 USA

U.S. Vet. License No. 112

50 DOSES

50-1 mL Vials

7831
03092
1296E

NAC No.: 10282410

BOEHRINGER INGELHEIM VETMEDICA, INC.
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
Telephone:   800-325-9167
Fax:   816-236-2717
Website:   www.bevaccinesmart.com
    www.bi-vetmedica.com
    www.productionvalues.us
    www.prrsresearch.com
    www.thinkmetacam.com
    www.vetera-vaccines.com
    www.vetmedin-us.com
    www.yourdogsheart.com
Email:   info@productionvalues.us
Every effort has been made to ensure the accuracy of the Fel-O-Vax FIV information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-12-03

(web3)